STOCK TITAN

Rockwell Medical to Release Second Quarter 2024 Results on Thursday, August 8, 2024

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary

Rockwell Medical (Nasdaq: RMTI) announced it will release its financial and operational results for the second quarter of 2024 on August 8, 2024. The announcement will be made at 6:00am ET, followed by a live conference call and webcast at 8:00am ET. Rockwell Medical, a healthcare company specializing in hemodialysis products, will discuss the financial and operational results for the quarter ending June 30, 2024, and hold a Q&A session. The conference can be accessed via phone at (888) 660-6347 (domestic) or (929) 201-6594 (international) using Conference Call ID: 4944610, or via webcast at www.RockwellMed.com/Results.

Positive
  • Announcement of financial and operational results for Q2 2024.
Negative
  • None.

WIXOM, Mich.--(BUSINESS WIRE)-- Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second quarter ended June 30, 2024 on Thursday, August 8, 2024. The Company will issue a press release at 6:00am ET followed by a live conference call and webcast at 8:00am ET.

CONFERENCE CALL AND WEBCAST DETAILS

Date: Thursday, August 8, 2024

Time: 8:00am ET

Live Number: (888) 660-6347 // (International) 1 (929) 201-6594

Conference Call ID: 4944610

Webcast and Replay: www.RockwellMed.com/Results

Format: Discussion of second quarter 2024 financial and operational results followed by Q&A.

ABOUT ROCKWELL MEDICAL

Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is usually performed at freestanding outpatient dialysis centers, at hospital-based outpatient centers, at skilled nursing facilities, or in a patient’s home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease, and the Company is relentless in providing unmatched reliability and customer service. Rockwell Medical is the largest supplier of liquid bicarbonate concentrates and the second largest supplier of acid and dry bicarbonate concentrates for dialysis patients in the United States and has the vision of becoming the leading global supplier of all hemodialysis concentrates. Certified as a Great Place to Work® in 2023 and 2024, Rockwell Medical is Driven to Deliver Life-Sustaining Dialysis SolutionsTM. For more information, visit www.RockwellMed.com.

Heather R. Hunter

SVP, Chief Corporate Affairs Officer

(248) 432-1362

IR@RockwellMed.com

Source: Rockwell Medical, Inc.

FAQ

When will Rockwell Medical release its second quarter 2024 financial results?

Rockwell Medical plans to release its second quarter 2024 financial results on Thursday, August 8, 2024.

What time will Rockwell Medical announce its Q2 2024 results?

Rockwell Medical will announce its Q2 2024 results at 6:00am ET on August 8, 2024.

How can I access the Rockwell Medical Q2 2024 earnings call?

You can access the earnings call by dialing (888) 660-6347 domestically, (929) 201-6594 internationally, using Conference Call ID: 4944610, or via webcast at www.RockwellMed.com/Results.

What is the stock symbol for Rockwell Medical?

The stock symbol for Rockwell Medical is RMTI.

What will be discussed during Rockwell Medical's Q2 2024 conference call?

Rockwell Medical will discuss its financial and operational results for the second quarter of 2024, followed by a Q&A session.

What is the focus of Rockwell Medical's business?

Rockwell Medical specializes in developing, manufacturing, commercializing, and distributing hemodialysis products to dialysis providers worldwide.

Rockwell Medical, Inc. (DE)

NASDAQ:RMTI

RMTI Rankings

RMTI Latest News

RMTI Stock Data

71.91M
28.56M
12.33%
21.27%
2.65%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
WIXOM